Showing 2401-2410 of 2656 results for "".
- ObjectiveEd Joins Microsoft’s AI for Accessibility Program to Develop Braille AI Tutor Platformhttps://modernod.com/news/objectiveed-joins-microsofts-ai-for-accessibility-program-to-develop-braille-ai-tutor-platform/2477020/ObjectiveEd has joined Microsoft Corp.’s AI for Accessibility program to help further its efforts in maximizing educational outcomes for children with disabilities. As a component of ObjectiveEd’s inclusion in the program, Microsoft has awarded ObjectiveEd a grant that will provide ObjectiveEd wi
- ReNeuron Presents Positive Clinical Data at the American Academy of Ophthalmology Annual Meetinghttps://modernod.com/news/reneuron-presents-positive-clinical-data-at-the-american-academy-of-ophthalmology-annual-meeting/2477009/ReNeuron Group has announced that positive efficacy data were presented during the weekend at the American Academy of Ophthalmology Annual Meeting (AAO) in San Francisco from the company’s phase 1/2a clinical trial of its hRPC stem cell therapy in retinitis
- Regenxbio Announces Additional Positive Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-announces-additional-positive-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd/2476995/Regenxbio announced interim data from the ongoing phase 1/2a trial of RGX-314 for the treatment of wet age-related macular degeneration (AMD). The results were presented by Jeffrey S. Heier, MD, Co-President and Director of Retina Research at Ophthalmic Consultants
- Oxurion NV to Provide Business and Clinical Update at AAO and OIS Meetings in San Franciscohttps://modernod.com/news/oxurion-nv-to-provide-business-and-clinical-update-at-aao-and-ois-meetings-in-san-francisco/2476969/Oxurion NV announces that the company will be providing a business and clinical update at the American Academy of Ophthalmology’s annual meeting (AAO) and Ophthalmology Innovation Summit (OIS@AAO) in San Francisco. Patrik De Haes, MD, CEO of Oxurion will be presenting the company’s b
- LensGen to Review Latest Juvene IOL Results At AAOhttps://modernod.com/news/lensgen-to-review-latest-juvene-iol-results-at-aao/2476954/LensGen will review its latest data for the world’s first modular fluid optic IOL in several activities around the American Academy of Ophthalmology (AAO) annual meeting in San Francisco this week. LensGen developed Juvene, which uses biomimetic design princ
- Santen Expands Into Surgical Devices and Publishes Real-World Evidence in Dry Eye Diseasehttps://modernod.com/news/santen-expands-into-surgical-devices-and-publishes-real-world-evidence-in-dry-eye-disease/2476923/In addition to launching a new monofocal, hydrophobic IOL, xact Mono-EDoF, a panel of experts including Ike K. Ahmed, reviewed current surgical techniques and introduced Santen’s Preserflo MicroShunt device at the recent ESCRS meeting in Paris. Preserflo MicroShunt is a surgical dev
- EyePoint Pharmaceuticals Announces Yutiq Presentations at AAO Annual Meetinghttps://modernod.com/news/eyepoint-pharmaceuticals-announces-yutiq-presentations-at-aao-annual-meeting/2476921/EyePoint Pharmaceuticals announced that two abstracts supporting the company’s Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year microinsert for chronic, noninfectious uveitis affecting the posterior segment of the eye have been accepted for presentation at the American Aca
- Pharmaceutical Companies Face Steeper Price Cuts in China as Country Expands Drug Bulk-Buying Scheme Nationwidehttps://modernod.com/news/pharmaceutical-companies-face-steeper-price-cuts-in-china-as-country-expands-drug-bulk-buying-scheme-nationwide/2476915/China has expanded across the country a drug procurement program aimed at reducing the cost of generic medicines, a move that may force global pharmaceutical firms to slash their prices by half in order to maintain sales to the country’s public hospitals, Bloomberg
- Sifi Appoints New Country Manager for Italyhttps://modernod.com/news/sifi-appoints-new-country-manager-for-italy/2476904/Sifi has announced that Fabrizio Folco has joined the company as “Country Manager Italy,” and will be responsible for accelerating company development on the Italian market through management of the company’s commercial strategy and organization, for both pharma and surgical are
- Canon Xephilio OCT-A1 Device Receives FDA 510(k) Clearancehttps://modernod.com/news/canon-xephilio-oct-a1-device-receives-fda-510k-clearance/2476889/Expanding the company’s lineup of eye care product offerings, Canon USA announced the new intuitive Xephilio OCT-A1 device. This device features automated acquisition functionality, which makes it easy to use, allowing healthcare professionals to obtain high